Open Access
ARTICLE
Hui Li*1, Han-Han Li†1, Qian Chen‡1, Yu-Yang Wang‡, Chang-Chang Fan‡, Yuan-Yuan Duan‡,
You Huang‡, Hui-Min Zhang‡, Jia-Peng Li‡, Xiao-Yu Zhang‡, Yuan Xiang‡, Chao-Jiang Gu‡, Li Wang§, Xing-Hua Liao‡, Tong-Cun Zhang‡¶
Oncology Research, Vol.28, No.9, pp. 885-897, 2020, DOI:10.3727/096504021X16274672547967
Abstract Abnormal cell proliferation caused by abnormal transcription regulation mechanism seems to be one of the
reasons for the progression of breast cancer and also the pathological basis. MicroRNA-142-5p (miR-142-5p)
is a low-expressed miRNA in breast cancer. The role of MKL-1’s regulation of DNMT1 in breast cancer cell
proliferation and migration is still unclear. MKL-1 (myocardin related transcription factor A) can bind to the
conserved cis-regulatory element CC (A/T) 6GG (called CarG box) in the promoter to regulate the transcription
of miR-142-5p. The expressions of miR-142-5p and MKL-1 are positively correlated. In addition, it has been
proved that DNMT1 is the… More >
Open Access
ARTICLE
Rosa Della Monica*1, Mariella Cuomo*†1, Roberta Visconti‡, Annabella di Mauro§, Michela Buonaiuto*,
Davide Costabile*†, Giulia De Riso†, Teodolinda Di Risi*, Elia Guadagno¶, Roberto Tafuto#,
Sabrina Lamia**, Alessandro Ottaiano††, Paolo Cappabianca#, Maria Laura Del Basso de Caro¶, Fabiana Tatangelo§, Juergen Hench‡‡, Stephan Frank‡‡, Salvatore Tafuto**, Lorenzo Chiariotti*†
Oncology Research, Vol.28, No.9, pp. 837-845, 2020, DOI:10.3727/096504021X16214197880808
Abstract Unresectable neuroendocrine neoplasms (NENs) often poorly respond to standard therapeutic approaches.
Alkylating agents, in particular temozolomide, commonly used to treat high-grade brain tumors including glioblastomas, have recently been tested in advanced or metastatic NENs, where they showed promising response
rates. In glioblastomas, prediction of response to temozolomide is based on the assessment of the methylation
status of the MGMT gene, as its product, O6
-methylguanine-DNA methyltransferase, may counteract the damaging effects of the alkylating agent. However, in NENs, such a biomarker has not been validated yet. Thus, we
have investigated MGMT methylation in 42 NENs of different grades and from… More >
Open Access
ARTICLE
Chiara Dalle Fratte*, Silvia Mezzalira*, Jerry Polesel†, Elena De Mattia*, Antonio Palumbo‡, Angela Buonadonna§, Elisa Palazzari¶, Antonino De Paoli¶, Claudio Belluco#, Vincenzo Canzonieri‡** , Giuseppe Toffoli*, Erika Cecchin*
Oncology Research, Vol.28, No.9, pp. 847-855, 2020, DOI:10.3727/096504021X16232280278813
Abstract Pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
is related to a favorable prognosis. The identification of early biomarkers predictive of pathological complete
response would help optimize the multimodality management of the patients. A panel of 11 tumor-related
proteins was investigated by immunohistochemistry in the pretreatment biopsy of a group of locally advanced
rectal cancer patients to identify early biomarkers of pathological complete response to neoadjuvant chemoradiotherapy. A mono-institutional retrospective cohort of 95 stage II/III locally advanced rectal cancer patients
treated with neoadjuvant chemoradiotherapy and surgery was selected based on clinical–pathological characteristics and the availability of… More >
Open Access
ARTICLE
Weili Min*1, Liangzhang Sun†1, Burong Li‡, Xiao Gao*, Shuqun Zhang*, Yang Zhao*
Oncology Research, Vol.28, No.9, pp. 857-872, 2020, DOI:10.3727/096504021X16203818567367
Abstract EMT confers increased metastatic potential and the resistance to chemotherapies to cancer cells. However, the
precise mechanisms of EMT-related chemotherapy resistance remain unclear. c-Src-mediated caspase 8 phosphorylation essential for EMT in lung adenocarcinoma cell lines preferentially occurs in cells with the mesenchymal phenotype, resulting in chemoresistance to cisplatin plus paclitaxel in patients with resectable lung
adenocarcinoma and a significantly worse 5-year PFS. Cisplatin killed lung adenocarcinoma cells regardless of
caspase 8. Paclitaxel-triggered necroptosis in lung adenocarcinoma cells was dependent on the phosphorylation
or deficiency of caspase 8, during which FADD interacted with RIPK1 to activate the RIPK1/RIPK3/MLKL
signaling axis. Accompanied… More >
Open Access
ARTICLE
Elena Andreucci*1, Anna Laurenzana*, Silvia Peppicelli*, Alessio Biagioni*, Francesca Margheri*, Jessica Ruzzolini*, Francesca Bianchini*, Gabriella Fibbi*, Mario Del Rosso*†, Chiara Nediani*, Simona Serratì‡, Livia Fucci§, Michele Guida¶, Lido Calorini*†1
Oncology Research, Vol.28, No.9, pp. 873-884, 2020, DOI:10.3727/096504021X16273798026651
Abstract Malignant melanoma is a highly aggressive skin cancer characterized by an elevated grade of tumor cell plasticity. Such plasticity allows adaptation of melanoma cells to different hostile conditions and guarantees tumor
survival and disease progression, including aggressive features such as drug resistance. Indeed, almost 50% of
melanoma rapidly develop resistance to the BRAFV600E inhibitor vemurafenib, with fast tumor dissemination,
a devastating consequence for patients’ outcomes. Vasculogenic mimicry (VM), the ability of cancer cells to
organize themselves in perfused vascular-like channels, might sustain tumor spread by providing vemurafenibresistant cancer cells with supplementary ways to enter into circulation and disseminate. Thus, this… More >
Open Access
ARTICLE
Hossam Kamli*, Gaffar S. Zaman*, Ahmad Shaikh*, Abdullah A. Mobarki†, Prasanna Rajagopalan*‡
Oncology Research, Vol.28, No.9, pp. 899-911, 2020, DOI:10.3727/096504021X16281573507558
Abstract Inhibition of the dihydroorotate dehydrogenase (DHODH) has been successful at the preclinical level in controlling myeloid leukemia. However, poor clinical trials warrant the search for new potent DHODH inhibitors.
Herein we present a novel DHODH inhibitor SBL-105 effective against myeloid leukemia. Chemical characteristics were identified by 1
H NMR, 13C NMR, and mass spectroscopy. Virtual docking and molecular dynamic
simulation analysis were performed using the automated protocol with AutoDock-VINA, GROMACS program.
Human-recombinant (rh) DHODH was used for enzyme inhibition study. THP-1, TF-1, HL-60, and SKM-1
cell lines were used. MTT assay was used to assess cell viability. Flow cytometry was… More >
Open Access
ARTICLE
Ziyi Wang*, Xinyu Zhang*, Xuedong Zhang†, Xuedong Jiang‡, Wenya Li*
Oncology Research, Vol.28, No.9, pp. 913-927, 2020, DOI:10.3727/096504021X16310057751016
Abstract Long intergenic nonprotein-coding RNA 1703 (LINC01703) has diagnostic significance in lung adenocarcinoma. However, its specific roles in non-small cell lung cancer (NSCLC) and downstream mechanisms have
not been investigated. In the current study, we characterized the role of LINC01703 in NSCLC malignancy
and elucidated its detailed mechanism of action. LINC01703 expression was measured by qRT-PCR. The
regulatory effects of LINC01703 on the malignancy of NSCLC cells were assessed by multiple functional
experiments. The targeted interaction was confirmed by RNA immunoprecipitation and luciferase reporter
assays. Herein, overexpression of LINC01703 in NSCLC was indicated in the TCGA database and further
proven in… More >
Open Access
ARTICLE
Heming Lu*†1, Yuying Wu‡1, Xu Liu†, Huixian Huang†, Hailan Jiang†, Chaohua Zhu†, Yuping Man§, Zhaohong Chen†, Xianfeng Long†, Qiang Pang†, Luxing Peng†, Xianglong Li†, Junzhao Gu†, Shan Deng†, Ligang Xing*
Oncology Research, Vol.28, No.9, pp. 929-944, 2020, DOI:10.3727/096504021X16318716607908
Abstract This phase II randomized clinical trial aimed to assess the efficacy and toxicity of Endostar, an antiangiogenesis
inhibitor, combined with concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer (LACC).
Patients with LACC were randomly assigned to either CCRT plus Endostar (CCRT+E arm) or CCRT alone
(CCRT arm). All patients received pelvic intensity-modulated radiation therapy (IMRT) and brachytherapy.
Weekly cisplatin was administered concurrently with IMRT. Patients in the CCRT+E arm also received concurrent Endostar every 3 weeks for two cycles. The primary endpoint was progression-free survival (PFS)
and acute toxicities. The exploratory endpoint was the impact of vascular endothelial growth factor… More >
Open Access
ARTICLE
Guojie Chen*1, Kai Wang*1, Guoshu Li†1, Leidong Wang‡, Yangyang Xiao§, Bo Chen¶
Oncology Research, Vol.28, No.9, pp. 945-959, 2020, DOI:10.3727/096504021X16328213967104
Abstract Long noncoding RNA LAMTOR5 antisense RNA 1 (LAMTOR5-AS1) has been certified as a risk predictor and
diagnostic biomarker of prostate cancer. However, the expression and exact roles of LAMTOR5-AS1 in nonsmall cell lung cancer (NSCLC) remain unclear. Thus, we measured LAMTOR5-AS1 expression in NSCLC
and gauged its clinical value. The detailed roles and downstream working mechanism of LAMTOR5-AS1 in
NSCLC were comprehensively unraveled. qRT-PCR was applied to measure gene expression. Functionally,
utilizing small interfering RNA, LAMTOR5-AS1 was ablated, and the functional alterations were addressed
by means of different experiments. The targeting activities between LAMTOR5-AS1 and microRNA-506-3p
(miR-506-3p) and between miR-506-3p… More >
Open Access
ERRATUM
Jianjun Shen*1, Weina Niu†1, Hongbo Zhang*, Ma Jun*, Hongyan Zhang*
Oncology Research, Vol.28, No.9, pp. 961-963, 2020, DOI:10.3727/096504022X16414984936746
Abstract Gastric cancer is the fourth most common malignancy and the third leading cause of cancer-related deaths
worldwide. This study aimed to investigate the expression patterns, biological roles, and underlying mechanisms of microRNA-147 (miR-147) in gastric cancer. The present study demonstrated that miR-147 was
significantly upregulated in gastric cancer tissues and cell lines. Downregulation of miR-147 decreased cell
proliferation and enhanced the chemosensitivity of gastric cancer cells to 5-fluorouracil (5-FU) through the
cell apoptosis pathway. In addition, phosphatase and tensin homolog (PTEN) was mechanically identified as
the direct target of miR-147 in gastric cancer. PTEN knockdown reversed the effects of miR-147… More >
Open Access
ERRATUM
Xin Chen*, Mingzhe Li†, Hongwei Zhou*, Li Zhang*
Oncology Research, Vol.28, No.9, pp. 965-967, 2020, DOI:10.3727/096504022X16414984936764
Abstract MicroRNA-132 (miR-132) has been demonstrated to be a tumor suppressor in several types of tumors. However,
the expression and the role of miR-132 in human thyroid cancer are still poorly understood. The aim of the
present study was to examine the potential roles and molecular mechanism of miR-132 in thyroid cancer. We
found that miR-132 expression levels were significantly downregulated in thyroid cancer tissues and cell lines.
Function assays showed that overexpression of miR-132 in TPC1 cells inhibited cell proliferation, migration,
and invasion. Forkhead box protein A1 (FOXA1) was identified as a direct target of miR-132 in thyroid cancer
cells.… More >
Open Access
ERRATUM
Tao Wang, Fan Shi, JiQuan Wang, Zi Liu, Jin Su
Oncology Research, Vol.28, No.9, pp. 969-970, 2020, DOI:10.3727/096504022X16414984936773
Abstract Kallistatin has been recognized as an endogenous angiogenesis inhibitor and exerts pleiotropic effects in inhibiting tumor growth, migration, apoptosis, and inflammation. The purpose of the present study was to investigate the potential role and mechanisms of kallistatin in cervical cancer. We demonstrated that kallistatin
effectively inhibited cell proliferation and enhanced apoptosis in a dose-dependent manner. Additionally, kallistatin suppressed migration and invasion activities and markedly reduced the expression of matrix-degrading
metalloproteinases, progelatinase (MMP-2), MMP-9, and urokinase-type PA (uPA). Kallistatin reversed the
epithelial–mesenchymal transition (EMT) and caused the upregulation of epithelial markers such as E-cadherin
and inhibited mesenchymal markers such as N-cadherin… More >
Open Access
ERRATUM
Wei Song*, Jia-Zhuan Mei†, Mingzhi Zhang‡
Oncology Research, Vol.28, No.9, pp. 971-972, 2020, DOI:10.3727/096504022X16414984936791
Abstract Accumulating evidence has indicated that long noncoding RNA (lncRNA) PlncRNA-1 plays an important
regulatory role in cancers. However, the expression and biological functions of PlncRNA-1 in colorectal cancer
(CRC) are still unclear. In the present study, we determined the expression of PlncRNA-1 in CRC and explored
the function of PlncRNA-1 on CRC cell progression. The results showed that PlncRNA-1 was significantly
increased in CRC tissues and cell lines; high PlncRNA-1 expression was associated with depth of invasion,
lymph node metastasis, and TNM stage of CRC patients. Kaplan–Meier curve analysis showed that patients
with high PlncRNA-1 expression had a poor overall… More >
Open Access
RETRACTION
Qingchun Li*, Yuan Tian†, Guangrui Hu†, Yun Liang†, Wei Bai†, Hongjun Li†
Oncology Research, Vol.28, No.9, pp. 973-973, 2020, DOI:10.3727/096504021X16303158875079
Abstract This article has no abstract. More >
Open Access
RETRACTION
Feng Shuai*, Bo Wang†, Shuxiao Dong‡
Oncology Research, Vol.28, No.9, pp. 975-975, 2020, DOI:10.3727/096504021X16297182567090
Abstract This article has no abstract. More >
Open Access
RETRACTION
Feng Shuai*, Bo Wang†, Shuxiao Dong‡
Oncology Research, Vol.28, No.9, pp. 977-977, 2020, DOI:10.3727/096504021X16297183140281
Abstract This article has no abstract. More >
Login
Register
Submit a Paper
Propose a Special lssue